GELYF(GELYF)
GELYF
No analyst ratings available
No analyst price targets available for GELYF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $417.94B | $487.93B | $542.30B | $468.85B | $467.94B |
| Low | $389.16B | $418.27B | $483.41B | $417.94B | $417.13B |
| High | $449.37B | $584.90B | $619.10B | $535.25B | $534.21B |
| EBITDA Avg | $40.17B | $47.20B | $54.15B | $42.40B | $43.31B |
| Low | $36.93B | $43.28B | $49.58B | $39.64B | $40.54B |
| High | $44.39B | $52.32B | $60.11B | $46.00B | $46.93B |
| EBIT Avg | $23.47B | $28.32B | $32.91B | $20.10B | $20.18B |
| Low | $20.23B | $24.40B | $28.34B | $17.34B | $17.41B |
| High | $27.68B | $33.43B | $38.87B | $23.70B | $23.80B |
| Net Income Avg | $21.71B | $26.31B | $30.66B | $18.53B | $18.60B |
| Low | $18.65B | $22.60B | $26.33B | $15.91B | $15.97B |
| High | $25.71B | $31.15B | $36.30B | $21.94B | $22.02B |
| EPS Avg | $2.10 | $2.54 | $2.96 | $1.79 | $1.80 |
| Low | $1.80 | $2.18 | $2.54 | $1.54 | $1.54 |
| High | $2.48 | $3.01 | $3.51 | $2.12 | $2.13 |
| Analysts (Rev / EPS) | 26 / 1 | 28 / 1 | 17 / 1 | 22 / 1 | 26 / 1 |
| Metric | Q4 2026 |
|---|---|
| Revenue Avg | $115.38B |
| Low | $115.38B |
| High | $115.38B |
| EBITDA Avg | — |
| Low | — |
| High | — |
| EBIT Avg | — |
| Low | — |
| High | — |
| Net Income Avg | — |
| Low | — |
| High | — |
| EPS Avg | — |
| Low | — |
| High | — |
| Analysts (Rev / EPS) | 1 / — |